ÂÜÀòÂÒÂ×

Jeffrey Kopacz is an experienced legal professional specializing in intellectual property and contracts within the biotechnology sector. Currently serving as Senior Vice President of Legal & Intellectual Property at City Therapeutics, Jeffrey has previously held significant positions including Senior Vice President and Head of Intellectual Property & Contracts at SalioGen Therapeutics, Vice President of Intellectual Property at Omega Therapeutics, and Senior Director and Senior Patent Counsel at Alnylam Pharmaceuticals. Before entering the biotechnology field, Jeffrey practiced as an attorney at Locke Lord LLP, contributing a strong legal background to their expertise in intellectual property matters.